REFERENCES
- Rizk E. A worldwide clinical overview of lomefloxacin, a once-daily fluoroquinolone. Int J Antimicrob Agents 1992; 2: 67–78.
- Siporin C. Lomefloxacin, the first once-daily fluoro-quinolone. Int J Antimicrob Agents 1991; 1.
- Siporin C. The evolution of fluorinated quinolones: pharmacology, microbiological activity, clinical uses and toxi-cities. Ann Rev Microbiol 1989; 43: 601–627.
- Hoffler D, Waetcke K, Koeppe P, Metz R, Sorgel F. Pharmacokinetics of lomefloxacin in normal and impaired renal function. Acta Therapeut 1989; 15: 321–336.
- Naber KG. Lomefloxacin versus norfloxacin versus ciprofloxacin in the treatment of complicated urinary tract infections. Int J Antimicrob Agents 1992; 2: 33–38.
- Sorgel F, Jaehde U, Naber KG, Stephan U. Pharmacokinetic disposition of quinolones in human body fluids and tissues. Chin Pharmacokinet 1989; 16 ( supp.1): 5-24.
- Kumon H, Kumamoto Y, Tsuchida S. A comparative study on lomefloxacin (NY-198) and norfloxacin in the treat-ment of complicated urinary tract infections. Chemotherapy 1989; 37: 336–362.
- Westenfelder M, Zeman W. A multicenter study of lomefloxacin versus ciprofloxacin in the treatment of compli-cated urinary tract infections. Int J Antimicrob Agents 1992; 2: 29–32.